Minute Insight: Are Things Going Pear-Shaped For Digital Therapeutics?
Pear Therapeutics is restructuring itself to lower costs following repeated disappointing performances.
You may also be interested in...
Massachusetts’ Medicaid program will cover reSET and reSET-O prescription digital therapeutics for the treatment of substance abuse disorder and opioid use disorder.
The company is trialing absorbable implants for both cosmetic and reconstructive surgeries.
In this edition of Medtech Monthly, Robert Gabbay, chief scientific and medical officer for the American Diabetes Association talked to Medtech Insight about diabetes tech, where it's headed, and what it could mean for preventative care.